Nectar Lifesciences Limited (NSE:NECLIFE)
India · Delayed Price · Currency is INR 15.42
-0.45 (-2.84%)
Aug 25, 2025, 3:29 PM IST
Nectar Lifesciences Market Cap
Nectar Lifesciences has a market cap or net worth of 3.46 billion as of August 25, 2025. Its market cap has decreased by -48.12% in one year.
Market Cap
3.46B
Enterprise Value
9.08B
Revenue
15.92B
Ranking
n/a
PE Ratio
n/a
Stock Price
15.42
Market Cap Chart
Since July 18, 2005, Nectar Lifesciences's market cap has increased from 2.87B to 3.46B, an increase of 20.68%. That is a compound annual growth rate of 0.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 3.56B | -59.29% |
| Dec 31, 2024 | 8.74B | 21.24% |
| Dec 29, 2023 | 7.21B | 30.96% |
| Dec 30, 2022 | 5.51B | -8.40% |
| Dec 31, 2021 | 6.01B | 12.13% |
| Dec 31, 2020 | 5.36B | 96.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,939.23B |
| Divi's Laboratories | 1,633.03B |
| Cipla | 1,293.38B |
| Apollo Hospitals Enterprise | 1,139.13B |
| Mankind Pharma | 1,075.90B |
| Zydus Lifesciences | 994.96B |
| Fortis Healthcare | 705.43B |
| Alkem Laboratories | 648.76B |